Seven Fleet Capital Management LP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Seven Fleet Capital Management LP disclosed 85 US equity positions worth $147.8m in its Q4 2025 13F filing. The largest position was CGON at 42.6% of the reported book, followed by COGT and SLNOEUR.
What did Seven Fleet Capital Management LP own in Q4 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | CGON CG ONCOLOGY INC | Healthcare | 42.6% | $62.9m | 1,515,151 | – | |
| 2 | COGT COGENT BIOSCIENCES INC | Healthcare | 5.1% | $7.6m | 214,099 | – | |
| 3 | SLNOEUR SOLENO THERAPEUTICS INC | 4.1% | $6.0m | 130,079 | – | ||
| 4 | 430 TERNS PHARMACEUTICALS INC | 3.6% | $5.3m | 130,413 | – | ||
| 5 | RVMD REVOLUTION MEDICINES INC | Healthcare | 3.5% | $5.2m | 65,800 | – | |
| 6 | LQDA LIQUIDIA CORPORATION | Healthcare | 2.1% | $3.1m | 91,267 | – | |
| 7 | CMPX COMPASS THERAPEUTICS INC | 2.1% | $3.1m | 568,747 | – | ||
| 8 | EXEL EXELIXIS INC | Healthcare | 2.0% | $3.0m | 68,569 | – | |
| 9 | ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 1.7% | $2.5m | 73,762 | – | |
| 10 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 1.6% | $2.4m | 12,955 | – | |
| 11 | TYRA TYRA BIOSCIENCES INC | Healthcare | 1.4% | $2.1m | 79,560 | – | |
| 12 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.3% | $1.9m | 215,172 | – | |
| 13 | ABVX ABIVAX SA | 1.2% | $1.8m | 13,499 | – | ||
| 14 | XNCR XENCOR INC | Healthcare | 1.1% | $1.7m | 109,554 | – | |
| 15 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 1.0% | $1.5m | 99,953 | – | |
| 16 | PHVS PHARVARIS N V | 1.0% | $1.5m | 55,342 | – | ||
| 17 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.0% | $1.5m | 42,025 | – | |
| 18 | BLTE BELITE BIO INC | Healthcare | 1.0% | $1.5m | 9,161 | – | |
| 19 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.9% | $1.4m | 70,180 | – | |
| 20 | NUVALENT INC | 0.9% | $1.3m | 12,601 | – | ||
| 21 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.8% | $1.2m | 5,670 | – | |
| 22 | AM6 AMICUS THERAPEUTICS INC | 0.8% | $1.2m | 82,500 | – | ||
| 23 | PCVX VAXCYTE INC | Healthcare | 0.8% | $1.2m | 25,365 | – | |
| 24 | AVTX AVALO THERAPEUTICS INC | Healthcare | 0.8% | $1.2m | 63,343 | – | |
| 25 | IKT INHIBIKASE THERAPEUTICS INC | 0.7% | $1.1m | 533,648 | – | ||
| 26 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.7% | $1.1m | 1,860 | – | |
| 27 | GERN GERON CORP | Healthcare | 0.7% | $1.0m | 777,880 | – | |
| 28 | KRYS KRYSTAL BIOTECH INC | Healthcare | 0.7% | $986.2k | 4,000 | – | |
| 29 | LONA ATHIRA PHARMA INC | 0.7% | $968.6k | 127,951 | – | ||
| 30 | TSHA TAYSHA GENE THERAPIES INC | Healthcare | 0.6% | $919.7k | 167,223 | – | |
| 31 | SLN SILENCE THERAPEUTICS PLC | 0.6% | $897.4k | 147,600 | – | ||
| 32 | ZURA ZURA BIO LTD | Healthcare | 0.6% | $872.5k | 166,500 | – | |
| 33 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.6% | $863.9k | 31,738 | – | |
| 34 | CELC CELCUITY INC | Healthcare | 0.6% | $831.6k | 8,338 | – | |
| 35 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.5% | $795.8k | 2,700 | – | |
| 36 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.5% | $781.9k | 48,412 | – | ||
| 37 | PALI PALISADE BIO INC | Healthcare | 0.5% | $769.6k | 327,500 | – | |
| 38 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 0.5% | $744.3k | 154,109 | – | |
| 39 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.5% | $698.7k | 8,000 | – | |
| 40 | CDTX CIDARA THERAPEUTICS INC | 0.5% | $668.4k | 3,026 | – | ||
| 41 | CYTK CYTOKINETICS INC | Healthcare | 0.4% | $656.7k | 10,335 | – | |
| 42 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.4% | $634.2k | 15,000 | – | |
| 43 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 0.4% | $633.4k | 1,300 | – | |
| 44 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.4% | $617.6k | 73,000 | – | |
| 45 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.4% | $603.8k | 14,651 | – | |
| 46 | MBX MBX BIOSCIENCES INC | Healthcare | 0.4% | $574.0k | 18,200 | – | |
| 47 | EOLS EVOLUS INC | Healthcare | 0.4% | $545.3k | 82,000 | – | |
| 48 | ZYME ZYMEWORKS INC | Healthcare | 0.4% | $542.4k | 20,600 | – | |
| 49 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 0.3% | $461.9k | 56,750 | – | |
| 50 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 0.3% | $456.0k | 14,654 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.